Cite
HARVARD Citation
Kunisada, T. et al. (n.d.). 3445A Final results of a randomized phase II study comparing trabectedin and best supportive care (BSC) in patients (pts) with translocation-related sarcomas (TRS). European journal of cancer. pp. S704-. [Online].